Indo Rama Synthetics (India) Ltd

Indo Rama Synthetics (India) Limited's Q2 and H1 FY2027 investor presentation outlines the company's financial performance, operational highlights, and strategic initiatives. The presentation highlights a significant improvement in earnings, with total income rising to Rs. 1,344 crore in Q2 FY27 compared to Rs. 1,222.4 crore in H1 FY26, driven by higher profitability and improved product mix. EBITDA increased to Rs. 117.7 crore in Q2 FY27, reflecting operational efficiency and cost discipline. The company reported a PAT of Rs. 74.1 crore in Q2 FY27, up from Rs. 24.6 crore in the same period last year. Financial metrics show improved cash generation, with cash flow rising to Rs. 325.8 crore in Q2 FY27. The company has expanded its manufacturing capacity, including a 2.28 lakh TPA PET resin line and enhanced DTY capacity. Strategic initiatives include a planned Rs. 200 crore expansion for specialty filament and fiber production at Butibori, expected to contribute benefits in FY27-28. The presentation also details the company's strong balance sheet, with total assets reaching Rs. 3,244.1 crore as of FY26, and a debt-equity ratio of 1.31x in H1 FY27. The company emphasizes its integrated operations, global technology partnerships, and focus on sustainability and ESG practices. The board of directors and core team are highlighted, along with the company's corporate structure and strategic relevance within the Indorama Ventures group. The presentation concludes with a thank you note from the company secretary.

The presentation highlights significant improvements in financial performance, operational efficiency, and strategic expansion plans, indicating a positive outlook.